2seventy bio, Inc. (TSVT) Tops Q2 EPS by 121c

2seventy bio, Inc. (NASDAQ: TSVT) reported Q2 EPS of $0.45, $1.21 better than the analyst estimate of ($0.76). Revenue for the quarter came in at $8.97 million versus the consensus estimate of $11.08 million.

For earnings history and earnings-related data on 2seventy bio, Inc. (TSVT) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Trump: 40-60% of chip manufacturing will be in the U.S. - CNBC Interview
• HSBC Upgrades Power Asset Holdings (6:HK) (HGKGF) to Buy